Education
About Us
Working with TipRanks
Follow Us
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 28.31M | $ 2.88M |
| Gross Profit | $ 0.00 | $ -1.17M | $ -1.06M | $ 27.08M | $ 1.06M |
| Operating Income | $ -44.99M | $ -35.74M | $ -23.73M | $ -25.47M | $ -15.72M |
| EBITDA | $ -50.27M | $ -32.97M | $ -23.55M | $ -51.92M | $ -15.53M |
| Net Income | $ -51.90M | $ -35.20M | $ -28.21M | $ -26.40M | $ -15.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.62M | $ 12.89M | $ 6.16M | $ 9.28M | $ 14.97M |
| Total Assets | $ 28.18M | $ 27.15M | $ 22.66M | $ 14.81M | $ 19.66M |
| Total Debt | $ 26.04M | $ 6.92M | $ 7.48M | $ 11.80M | $ 439.43K |
| Net Debt | $ 8.42M | $ -5.98M | $ 1.33M | $ 2.52M | $ -14.53M |
| Total Liabilities | $ 39.49M | $ 15.77M | $ 124.81M | $ 89.35M | $ 68.80M |
| Stockholders' Equity | $ -11.31M | $ 11.37M | $ -102.15M | $ -74.54M | $ -49.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -37.16M | $ -32.76M | $ -22.83M | $ -24.46M | $ -16.90M |
| Operating Cash Flow | $ -37.07M | $ -32.69M | $ -22.18M | $ -23.94M | $ -16.70M |
| Investing Cash Flow | $ -84.00K | $ -32.00K | $ -654.00K | $ -525.36K | $ -199.92K |
| Financing Cash Flow | $ 42.32M | $ 38.61M | $ 21.20M | $ 19.39M | $ 25.06M |